⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial

Official Title: Phase 2 Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial

Study ID: NCT05928806

Study Description

Brief Summary: This study is a randomized, open label, multicenter Phase II trial to evaluate the efficacy and safety of botensilimab (a novel Fc enhanced Tree depleting anti-CTLA4) and balstilimab (a novel anti-PD1) relative to ipilimumab and nivolumab in treatment naïve patients with metastatic ccRCC. The study will plan to enroll 120 eligible patients randomized in a 2:1 fashion to Arm A and Arm B. Patients in all IMDC Risk Groups are included. This study utilizes a Simon's two stage design which is described in the protocol. Patients randomized to Arm A will receive botensilimab in combination with balstilimab. Patients randomized to Arm B will receive ipilimumab in combination with nivolumab. Study treatment on both arms will continue until toxicity, disease progression or a maximum of 96 total weeks (12 weeks induction, 84 weeks maintenance).

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

University of California San Diego, La Jolla, California, United States

Yale University, Yale Cancer Center, New Haven, Connecticut, United States

Georgetown University, Washington, District of Columbia, United States

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Dana-Farber - Partners Cancer Care, Inc, Boston, Massachusetts, United States

Penn Medicine Abramson Cancer Center, Philadelphia, Pennsylvania, United States

Contact Details

Name: Michael B Atkins, MD

Affiliation: Georgetown University

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: